Withdrawals due to adverse events · women with heavy menstrual bleeding
It is very uncertain whether antifibrinolytics changes withdrawal from treatment because of adverse events compared with ethamsylate (very low certainty).
1 finding from 1 review
Thromboembolic events · women with heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Menstrual blood loss: mean loss · heavy menstrual bleeding
2 findings from 1 review
Rates of improvement · heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Menstrual blood loss: improvement rates · women with heavy menstrual bleeding
Antifibrinolytics probably leads to higher menstrual blood loss: improvement rates compared with no treatment or placebo (moderate certainty).
1 finding from 1 review
Adverse events (any) · heavy menstrual bleeding
It is very uncertain whether antifibrinolytics changes adverse events (any) compared with herbal medicines (very low certainty).
1 finding from 1 review
Thromboembolic events · heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Menstrual blood loss PBAC score · heavy menstrual bleeding
1 finding from 1 review
Menstrual blood loss: improvement in mean blood loss (PBAC score < 100) · heavy menstrual bleeding
It is very uncertain whether antifibrinolytics changes menstrual blood loss: improvement in mean blood loss (PBAC score <… compared with levonorgestrel intrauterine system (very low certainty).
1 finding from 1 review
Adverse events (any) · heavy menstrual bleeding
It is very uncertain whether antifibrinolytics changes adverse events (any) compared with levonorgestrel intrauterine system (very low certainty).
1 finding from 1 review
Thromboembolic events · heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (any) · women with heavy menstrual bleeding
Antifibrinolytics showed no clear difference in adverse events (any) compared with no treatment or placebo (low certainty).
1 finding from 1 review
Thromboembolic events · women with heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Menstrual blood loss: mean loss · women with heavy menstrual bleeding
1 finding from 1 review
Menstrual blood loss: improvement rates · women with heavy menstrual bleeding
Antifibrinolytics may leads to higher menstrual blood loss: improvement rates (overall) compared with progestogens (low certainty).
1 finding from 1 review
Adverse events (any) · women with heavy menstrual bleeding
Antifibrinolytics may leads to lower adverse events (any) compared with progestogens (low certainty).
1 finding from 1 review
Thromboembolic events · women with heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Menstrual blood loss: mean loss · women with heavy menstrual bleeding
1 finding from 1 review
Live birth rate · women starting donor sperm treatment
It is very uncertain whether intrauterine insemination changes live birth rate compared with intracervical insemination (very low certainty).
2 findings from 1 review
Cancellation rate · women starting donor sperm treatment
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found